Alliance for Childhood Diseases

Las Vegas, Nevada 89135

0 studies enrolling now · 5 studies all time

What they study most

Acute Lymphoblastic Leukemia, Hemophilia A, Hemophilia B, Leukemia, Lymphoblastic Leukemia, Recurrent and Refractory Solid Tumors, Secondary Prevention, Venous Thromboembolism

Studies at this site

• A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia — Completed
• A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%) — Completed
• An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) — Completed
• Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors — Completed
• Safety of Dabigatran Etexilate in Blood Clot Prevention in Children — Completed